Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TLTFF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Theralase Technologies Inc. stock upgraded to Sell Candidate.
(Updated on Apr 30, 2024)

Sell candidate since Apr 16, 2024 Loss -7.58% PDF

The Theralase Technologies Inc. stock price gained 2.48% on the last trading day (Tuesday, 30th Apr 2024), rising from $0.113 to $0.116. During the last trading day the stock fluctuated 2.11% from a day low at $0.115 to a day high of $0.117. The price has been going up and down for this period, and there has been a -7.58% loss for the last 2 weeks. Volume fell on the last day by -38 thousand shares and in total, 9 thousand shares were bought and sold for approximately $1.07 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.112 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -17.34% during the next 3 months and, with a 90% probability hold a price between $0.0930 and $0.132 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TLTFF Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 29, 2024, and so far it has risen 2.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Theralase Technologies Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.119 and $0.128. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Theralase Technologies Inc. stock

Theralase Technologies Inc. finds support from accumulated volume at $0.115 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0024 between high and low, or 2.11%. For the last week the stock has had daily average volatility of 3.86%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TLTFF) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Theralase Technologies Inc. to open at $0.116, and during the day (based on 14 day Average True Range), to move between $0.109 and $0.123, which gives a possible trading interval of +/-$0.0070 (+/-6.00%) up or down from last closing price. If Theralase Technologies Inc. takes out the full calculated possible swing range there will be an estimated 12.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.115 (0.69%) than the resistance at $0.122 (4.92%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Theralase Technologies Inc. stock A Buy?

Theralase Technologies Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.030 Sell Candidate Upgraded

Predicted Opening Price for Theralase Technologies Inc. of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$0.116 ( 0.109%) $0.116

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TLTFF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.118 2.20 %
R2 0.117 1.40 %
R1 0.117 0.91 %
Current price: 0.116
Support S1 0.115 -0.690 %
S2 0.114 -1.18 %
S3 0.114 -1.98 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.133 14.55 %
R2 0.124 6.99 %
R1 0.122 4.92 %
Current price 0.116
Support S1 0.115 -0.691%
S2 0.113 -2.42%
S3 0 .

FAQ

What is the symbol for Theralase Technologies Inc. Stock and on which exchange is it traded?
The symbol for Theralase Technologies Inc. is TLTFF and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Theralase Technologies Inc. Stock?
Theralase Technologies Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Theralase Technologies Inc. Stock?
Theralase Technologies Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Theralase Technologies Inc. Stock.

What's the current price of Theralase Technologies Inc. Stock?
As of the end of day on the Apr 30, 2024, the price of an Theralase Technologies Inc. (TLTFF) share was $0.116.

What is the 52-week high and low for Theralase Technologies Inc. Stock?
The 52-week high for Theralase Technologies Inc. Stock is $0.236 and the 52-week low is $0.112.

What is the market capitalization of Theralase Technologies Inc. Stock?
As of the Apr 30, 2024, the market capitalization of Theralase Technologies Inc. is 25.007M.

When is the next earnings date for Theralase Technologies Inc. ?
The upcoming earnings date for Theralase Technologies Inc. is Jun 19, 2024.
Click to get the best stock tips daily for free!

About Theralase Technologies Inc.

Theralase Technologies. Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to... TLTFF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT